ArticleThe international journal of cardiovascular imaging2026
Machine learning algorithms for predicting arrhythmic events in Hypertrophic Cardiomyopathy: limited enhancement beyond late gadolinium enhancement.
Article in The international journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comment on Carvalho et al.: CT-derived extracellular volume and the prediction target in severe aortic stenosis.The international journal of cardiovascular imaging · 2026Article
- Predicting sudden cardiac death in hypertrophic cardiomyopathy: the indispensable role of echocardiographic persistence before advanced algorithms.The international journal of cardiovascular imaging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We aimed to develop and assess the performance of a Machine learning (ML) model integrating common clinical features to predict arrhythmic events in patients with Hypertrophic Cardiomyopathy (HCM). Post-hoc analysis of an international multicenter registry of 531 HCM patients (49 years (IQR 35-61), 57% male) who underwent cardiac magnetic resonance (CMR). The dataset comprised clinical, echocardiographic, and CMR variables, including quantification of late gadolinium enhancement (LGE) using the + 6 SD method. The endpoint was a composite of sudden cardiac death (SCD), aborted SCD, and sustained ventricular tachycardia (VT). A total of 28 events occurred over a median follow-up of 4.1 (IQR 1.8-7.3) years. Several ML models were developed and the predictive performance of the best model was compared to the ESC HCM risk score and to the amount of LGE. The Random Forest (RF) was the most effective method showing a good performance for predicting arrhythmic events [AUC of 0.78 (95% CI: 0.76-0.82, p < 0.001)], substantially outperforming the ESC HCM risk score [AUC of 0.64 (95% CI 0.62-0.67; p < 0.001), p < 0.001 for comparison]. However, when compared to LGE alone [AUC of 0.76 (95% CI: 0.73-0.84, p < 0.001)], the RF model did not provide significant improvement in predicting the endpoint (p = 0.817 for comparison). A ML model using available clinical variables significantly outperformed the ESC HCM risk score in predicting arrhythmic events in HCM. However, its incremental value over LGE alone was weak, underscoring the strong predictive value of this imaging marker. This findings should be interpreted as exploratory and hypothesis-generating.
Indexed as
Identifiers
42479339What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.